From foodconsumer.org

Government
FDA to hold meeting on bisphenol A safety
By Sue Mueller
Aug 17, 2008 - 1:59:24 PM

If you like the article, could you please do us a favor? Just tell Google News Services that you like foodconsumer.org included in Google News Services. Inclusion in googlenewsservices means many more people can read articles like this. Thanks.
------

Andrew C. von Eschenbach, M.D. Commissioner of Food and Drugs. Credit: FDA
SUNDAY August 17, 2008 (foodconsumer.org) -- It's bisphenol A time again.   The Food and Drug Administration said on Friday that the agency will hold a public meeting next month to discuss the safety of a chemical commonly used in baby bottles and food containers such as beverage bottles and linings of canned food including baby formula cans.

 

The chemical of concern has worried environmental groups which say that bisphenol A (BPA) can hurt children and animals while regulators in the US and Europe as well as the plastics industry say it is safe to use.

 

Studies suggest that even at incredibly low levels this chemical can cause an effect on young animals. The National Toxicology Program, part of the U.S. government's National Institutes of Health, agreed in a draft report that bisphenol A could cause neural and behavioral problems in fetuses, infants and children.

 

The meeting is scheduled for Sept. 16.   Andrew C. von Eschenbach, M.D. Commissioner of the FDA says in his posting on the agency's website that citizens are welcome to make their voice heard.

 

A draft assessment has been posted saying that currently there has no sufficient information to judge at what levels people would be affected by bisphenol A and suggesting that further study of the chemical's safety is badly needed, Reuters reported.

 

Democrats in the Senate already introduced in April a bill to ban BPA in children's products while Canada is planning a ban on the chemical.

 

Some states have been considering legislation to prohibit use or restrict use of BPA in children products such as baby formulas cans.

 

Some retailers and manufacturers have decided to stop using BPA in some products or selling BPA containing products. But they said that their move is a response to the market demand, not an indicator that bisphenol A is unsafe to use.

 

Below is the message posted on the FDA website.

 

BPA: The Science, Evaluation and Safety

August 15, 2008


Welcome to Andy’s Take.

Since the splitting of the atom to now global warming, society has come to realize that, regarding science and technology, with progress comes peril! This is true for many of the products that FDA regulates and press reports can often cause great alarm. For example, you are now hearing that bisphenol A -- or BPA -- in plastic products might affect hormones in development and you may be seeing in stores plastic water bottles that are labeled “BPA Free.”

My Take on this is that science creates these products and science must inform us of their risks. With regard to BPA thus far, the science FDA has reviewed does not justify recommending that anyone discontinue using these products. But we continue to investigate new research regarding the safety of BPA. We are asking outside experts to review our work and are seeking as much technical input as possible. In September, we are holding a public meeting of such experts – as a subcommittee of our Science Board - to discuss FDA’s draft assessment of the safety of BPA in items that touch food.

By taking steps to get input from outside the agency including from you, the FDA continues to improve the process by which we evaluate the science. This also provides a way to get the most current information to you so that you can make informed decisions about using the wide variety of food packaging and food containers that use material like plastic.

Many of the FDA-regulated products -- like the water and infant bottles containing BPA -- have become an integral part of the busy lives that we all lead. The FDA of the 21st century continues to modernize to keep pace with advancements in science and technology and the availability of such new products -- and as the science involved continues to be more complex, we continue to improve our process of making science-based regulatory decisions.

I hope that you will stop by here next week to get the take from Dr. Randall Lutter -- FDA’s Deputy Commissioner for Policy.



Andy

Andrew C. von Eschenbach, M.D.
Commissioner of Food and Drugs


Notice of Meeting (Federal Register, Aug. 15, 2008)






© Copyright 2004 - 2008 foodconsumer.org All rights reserved